KindlyMD's board of directors approved a share buyback program to enhance capital allocation flexibility.

According to an official announcement, KindlyMD (NASDAQ: NAKA), a healthcare and Bitcoin treasury company, announced that its board of directors has approved a share repurchase program, allowing the company to repurchase its outstanding common stock from time to time in the future. KindlyMD stated that the program aims to enhance capital allocation flexibility and demonstrate management's confidence in the company's long-term value and its Bitcoin-related business strategy.

The announcement stated that the share repurchase can be conducted through open market transactions, privately negotiated transactions, block trades, or other legal means, and may also be implemented in accordance with the Rule 10b5-1 transaction plan. The specific timing, scale, and method of the repurchase will be determined by management based on factors such as market conditions, share price, trading volume, and capital needs. This plan does not constitute a mandatory repurchase commitment, and the board of directors may adjust, suspend, or terminate it at any time.

In August 2025, KindlyMD completed its merger with Nakamoto Holdings, a Bitcoin-native holding company, forming a listed entity that covers both healthcare services and Bitcoin treasury management.

Previous news: KindlyMD faces delisting risk from Nasdaq due to its stock price remaining below $1 for 30 consecutive trading days.